368 related articles for article (PubMed ID: 18574763)
1. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
[TBL] [Abstract][Full Text] [Related]
2. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
[TBL] [Abstract][Full Text] [Related]
3. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
Aoki M
Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
[TBL] [Abstract][Full Text] [Related]
4. Identification of two novel mutations in the Cu/Zn superoxide dismutase gene with familial amyotrophic lateral sclerosis: mass spectrometric and genomic analyses.
Sato T; Yamamoto Y; Nakanishi T; Fukada K; Sugai F; Zhou Z; Okuno T; Nagano S; Hirata S; Shimizu A; Sakoda S
J Neurol Sci; 2004 Mar; 218(1-2):79-83. PubMed ID: 14759637
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
[TBL] [Abstract][Full Text] [Related]
6. Familial amyotrophic lateral sclerosis.
Siddique T; Hentati A
Clin Neurosci; 1995-1996; 3(6):338-47. PubMed ID: 9021255
[TBL] [Abstract][Full Text] [Related]
7. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the Cu/Zn superoxide dismutase gene in 23 familial and 69 sporadic cases of amyotrophic lateral sclerosis in Belgium.
Aguirre T; Matthijs G; Robberecht W; Tilkin P; Cassiman JJ
Eur J Hum Genet; 1999 Jul; 7(5):599-602. PubMed ID: 10439968
[TBL] [Abstract][Full Text] [Related]
9. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis.
Rouleau GA; Clark AW; Rooke K; Pramatarova A; Krizus A; Suchowersky O; Julien JP; Figlewicz D
Ann Neurol; 1996 Jan; 39(1):128-31. PubMed ID: 8572658
[TBL] [Abstract][Full Text] [Related]
10. Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes.
Broom WJ; Russ C; Sapp PC; McKenna-Yasek D; Hosler BA; Andersen PM; Brown RH
Neurosci Lett; 2006 Jan; 392(1-2):52-7. PubMed ID: 16174551
[TBL] [Abstract][Full Text] [Related]
11. Expression of the copper-zinc superoxide dismutase gene in amyotrophic lateral sclerosis.
Nishiyama K; Murayama S; Kwak S; Kanazawa I
Ann Neurol; 1997 Apr; 41(4):551-6. PubMed ID: 9124814
[TBL] [Abstract][Full Text] [Related]
12. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H
J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376
[TBL] [Abstract][Full Text] [Related]
13. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis.
Liu D; Bao F; Wen J; Liu J
Neuroscience; 2007 Apr; 146(1):255-64. PubMed ID: 17368952
[TBL] [Abstract][Full Text] [Related]
14. Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients.
Zetterström P; Andersen PM; Brännström T; Marklund SL
J Neurochem; 2011 Apr; 117(1):91-9. PubMed ID: 21226712
[TBL] [Abstract][Full Text] [Related]
15. The G93C mutation in superoxide dismutase 1: clinicopathologic phenotype and prognosis.
Régal L; Vanopdenbosch L; Tilkin P; Van den Bosch L; Thijs V; Sciot R; Robberecht W
Arch Neurol; 2006 Feb; 63(2):262-7. PubMed ID: 16476815
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid Flt3 ligand level in patients with amyotrophic lateral sclerosis.
Iłzecka J
Acta Neurol Scand; 2006 Sep; 114(3):205-9. PubMed ID: 16911350
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype.
Zetterberg H; Jacobsson J; Rosengren L; Blennow K; Andersen PM
Eur J Neurol; 2007 Dec; 14(12):1329-33. PubMed ID: 17903209
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel D109Y mutation in Cu/Zn superoxide dismutase (sod1) gene associated with amyotrophic lateral sclerosis.
Naini A; Mehrazin M; Lu J; Gordon P; Mitsumoto H
J Neurol Sci; 2007 Mar; 254(1-2):17-21. PubMed ID: 17257622
[TBL] [Abstract][Full Text] [Related]
19. Genetic mapping of a mouse modifier gene that can prevent ALS onset.
Kunst CB; Messer L; Gordon J; Haines J; Patterson D
Genomics; 2000 Dec; 70(2):181-9. PubMed ID: 11112346
[TBL] [Abstract][Full Text] [Related]
20. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
Gomes C; Keller S; Altevogt P; Costa J
Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
